PR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PR is not a good buy right now for an impatient buyer. The trend is bullish, but the stock is stretched/overbought (RSI_6 88) and is trading just above near-term resistance (15.90), which raises the odds of a pullback before the next clear upside leg. With insiders aggressively selling recently and the oil macro framed as oversupplied by multiple analysts, the risk/reward for an immediate entry is unfavorable despite bullish options positioning.
Trend is bullish: SMA_5 > SMA_20 > SMA_200 confirms an uptrend, and MACD histogram (+0.171) is positive and expanding (momentum still improving). However, RSI_6 at ~88.47 signals a near-term overbought condition (commonly followed by consolidation/pullback). Price levels: pivot ~15.082; support S1 ~14.269 (then S2 ~13.766). Resistance: R1 ~15.896 has been exceeded slightly (current ~15.955), with next resistance R2 ~16.399. Given the overbought reading and being near resistance, the setup favors waiting for either (1) a pullback toward pivot/15.1–14.3 or (2) a clean break and hold above ~16.40. Pattern-based odds provided also skew slightly negative over 1W–1M (-2.12% week, -3.57% month).
Event catalyst: Q4/FY2025 earnings scheduled Feb 25, 2026 (call Feb
can re-rate shares if capital discipline/free cash flow holds up.
Institutional/flow signal: Hedge funds are reported as buying aggressively (large QoQ increase), supportive of the medium-term bull case.
Options sentiment is strongly call-skewed, which can support upside continuation if price breaks above ~16.40.
Near-term technical risk: extremely overbought RSI and price sitting near/just above resistance increases pullback probability for an immediate entry.
Insider activity: insiders are selling heavily recently (sharp MoM increase), which is a near-term confidence headwind.
Macro/commodity narrative: multiple analysts cite oversupplied oil market and downward pressure on pricing (OPEC supply/non-OPEC growth), which can cap E&P multiples and cash flow expectations.
Latest provided quarter: 2025/Q3. Revenue grew to $1.322B (+8.74% YoY), but profitability deteriorated sharply: net income $59.2M (-84.67% YoY) and EPS $0.08 (-84.91% YoY). Gross margin fell to ~33.9% (-7.81% YoY). Net: top-line growth is positive, but earnings/margins compressed meaningfully, consistent with a less favorable realized pricing/cost mix; this weakens the case for chasing the stock at an overbought level ahead of the next earnings catalyst.
Recent Street trend: price targets have generally been trimmed/held steady due to a weaker oil macro backdrop (e.g., Susquehanna $20->18, Morgan Stanley $19->18, JPMorgan $19->18), while Wells Fargo nudged up to $17 from $16 and kept Overweight. BofA downgraded to Neutral with a $16 PT after strong relative performance. Overall, the pros view: operational execution/capital discipline and cash-flow framework are attractive; cons view: near-term oil oversupply and price-deck reductions limit upside. Net: still broadly constructive ratings, but expectations are being moderated.
